Screener
Ocular Therapeutix OCUL Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Derivative liability | 12,071 | 13,903 |
| Deferred revenue | 14,000 | 14,000 |
| Notes payable, net | 72,062 | 71,336 |
| Other non-current liabilities | 909 | 887 |
| Total liabilities | 150,955 | 153,747 |
| Commitments and contingencies (Note 14) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's other non-current liabilities?
- Ocular Therapeutix (OCUL) reported other non-current liabilities of $909K in Q1 2026.
- How has Ocular Therapeutix's other non-current liabilities changed year-over-year?
- Ocular Therapeutix's other non-current liabilities increased by 531.3% year-over-year, from $144K to $909K.
- What is the long-term trend for Ocular Therapeutix's other non-current liabilities?
- Over 3 years (2022 to 2025), Ocular Therapeutix's other non-current liabilities has grown at a 112.1% compound annual growth rate (CAGR), from $93K to $887K.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Ocular Therapeutix's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude